Authors' reply to Reed.
Warraich, Haider J, Pankaj Kumar, and Rishi K Wadhera. 2022. “Authors’ Reply to Reed.”. BMJ (Clinical Research Ed.) 378: o1871.
Search
Search results
264 results found
Primary Care Physician Supply by County-Level Characteristics, 2010-2019.
Liu, Michael, and Rishi K Wadhera. 2022. “Primary Care Physician Supply by County-Level Characteristics, 2010-2019.”. JAMA 328 (19): 1974-77.
Hospitals and Health Equity - Translating Measurement into Action.
Sandhu, Sahil, Michael Liu, and Rishi K Wadhera. 2022. “Hospitals and Health Equity - Translating Measurement into Action.”. The New England Journal of Medicine 387 (26): 2395-97.
Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act.
Narasimmaraj, Prihatha R, Andrew Oseran, Archana Tale, Jiaman Xu, Utibe R Essien, Dhruv S Kazi, Robert W Yeh, and Rishi K Wadhera. 2023. “Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act.”. Journal of the American College of Cardiology 81 (15): 1491-1501.
Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes.
Essien, Utibe R, Balvindar Singh, Gretchen Swabe, Amber E Johnson, Lauren A Eberly, Rishi K Wadhera, Khadijah Breathett, Muthiah Vaduganathan, and Jared W Magnani. 2023. “Association of Prescription Co-Payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes.”. JAMA Network Open 6 (6): e2316290.
Cardiovascular hospitalizations for Medicare advantage beneficiaries in the United States, 2009 to 2019.
Oseran, Andrew S, Huaying Dong, and Rishi K Wadhera. 2023. “Cardiovascular Hospitalizations for Medicare Advantage Beneficiaries in the United States, 2009 to 2019.”. American Heart Journal 265: 77-82.
Advancing Cardiovascular Health Equity in the United States: Now That We Know, Where Do We Go Next?
Wadhera, Rishi K, Karol E Watson, and Mercedes R Carnethon. 2023. “Advancing Cardiovascular Health Equity in the United States: Now That We Know, Where Do We Go Next?”. Circulation 148 (3): 197-98.
Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults-Reply.
Aggarwal, Rahul, and Rishi K Wadhera. 2023. “Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults-Reply.”. JAMA 330 (4): 379-80.
Pharmaco-disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries.
Averbuch, Tauben, Meisam Esfahani, Rani Khatib, James Kayima, Juan Jaime Miranda, Rishi K Wadhera, Faiez Zannad, Ambarish Pandey, and Harriette G C Van Spall. 2023. “Pharmaco-Disparities in Heart Failure: A Survey of the Affordability of Guideline Recommended Therapy in 10 Countries.”. ESC Heart Failure 10 (5): 3152-63.
Cardiovascular Health of Middle-Aged U.S. Adults by Income Level, 1999 to March 2020 : A Serial Cross-Sectional Study.
Liu, Michael, Rahul Aggarwal, ZhaoNian Zheng, Robert W Yeh, Dhruv S Kazi, Karen E Joynt Maddox, and Rishi K Wadhera. 2023. “Cardiovascular Health of Middle-Aged U.S. Adults by Income Level, 1999 to March 2020 : A Serial Cross-Sectional Study.”. Annals of Internal Medicine 176 (12): 1595-1605.